$CCRN

Allen Dwayne sold (to issuer) $415K of CCRN

Allen Dwayne sold (to issuer) 31,289 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($0.41M total) on 2026-07-21.

Original reporting
SEC EDGAR · Allen Dwayne
Published Jul 21, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCRN
Neutral
medium confidence
Mentioned
$CCRN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The newest fact is the director’s sale of 31,289 shares to the issuer for $414,579.25 at $13.25 on 2026-07-21.

02

Market read

Traders may note insider selling, but the disclosure alone is unlikely to drive a durable repricing without accompanying operational or guidance news.

03

What to watch

No 10b5-1 plan is stated, but the filing does not provide intent or future trading; also, the director ends with 0 shares, which can reflect diversification rather than timing.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-21, after-hours/late day SEC Form 4 disclosure.

Background

The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare (CCRN).

Company-level read

Ticker impact

$CCRNNeutralMedium confidence
Context

Cross Country Healthcare director Allen Dwayne sold 31,289 shares to the issuer for about $414.6K at $13.25 on 2026-07-21.

Expected impact

Low near-term impact; any effect is likely sentiment-only and should fade unless follow-on insider activity or fundamentals change.

Evidence & confidence

Form 4 shows a director sale to issuer at a fixed price, with holdings after transaction at 0 shares and no 10b5-1 plan noted. This is typically not a fundamental catalyst by itself, but it can slightly affect sentiment around insider confidence.

Market effects

None; this is company-specific insider transaction data.

None.

None.

Counterpoint

Because the code indicates sale to issuer, the transaction may be mechanical (e.g., buyback participation) rather than a bearish view on prospects.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction disclosure.

  • Allen Dwayne

    Director who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).

$DOLELow

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $8.6M of DOLE (indirect holdings)

Pale Fire Capital SE purchased 648,356 indirectly-held shares of Dole plc (DOLE) at an average of $13.19 ($13.12–$13.39, $8.55M total) across 3 trades over 2026-10-20 to 2026-10-22. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).